For instance, PRMT5 overexpression or hyperactivation is observed in several tumor types, including acute myeloid leukemia, breast cancer, glioblastoma, lung, and prostate cancer, which facilitates tumor initiation and progression11–16. This evidence concerns the gene PRMT5 and neoplasm.